James Chang

6623997, Sep 23, 2003

Dec 15, 2000

09/738827

James Chang - Cupertino CA
Ronald T. Kaneshiro - Mountain View CA
Stefano G. Therisod - Sunnyvale CA

Agilent Technologies, Inc. - Palo Alto CA

H01L 2166

438 18, 438128, 438129, 438 14, 438 17, 438 5, 438 10, 438 11, 438 12

A submount substrate is used for the dual purposes of enabling simultaneous burn-in processing for a relatively large number of arrays of optical transmitters and enabling conventional dicing techniques to be used to form mounting-ready assemblies. In the preferred embodiment, the submount substrate is a silicon wafer that is specifically designed to provide connectivity between VCSEL arrays and burn-in equipment during the testing stage, but is also designed to be segmented and used in the final packaging stage. Because the submount is a silicon wafer, conventional integrated circuit fabrication techniques may be used to form conductive patterns that define array-receiving areas and that allow external circuitry to communicate with the various VCSEL arrays.

7021833, Apr 4, 2006

Mar 22, 2002

10/104249

James Chang - Cupertino CA, US
Pradeep Raj Komar - San Jose CA, US
Brenton A. Baugh - Palo Alto CA, US
Ronald T. Kaneshiro - Los Altos CA, US
Robert E. Wilson - Palo Alto CA, US
James Williams - Palo Alto CA, US

G02B 6/36

385 88, 385 92, 385 94

Waveguide based connector systems for optically coupling a fiber optic cable and an optoelectronic device and a method of fabricating the same are described. In one aspect, a connector system comprises an optical waveguide and an optical turn assembly. The optical waveguide has a first end and a second end. The first end of the optical waveguide is connectable to the fiber optic cable in an orientation aligned with a line-side connection axis. The optical turn assembly has a first optical port that is connected to the second end of the optical waveguide in an orientation aligned with a device-side connection axis, a second optical port that is oriented to communicate optically with the optoelectronic device along a device communication axis substantially intersecting the device-side connection axis, and an optical turn system that is operable to guide light along a path between the first optical port and the second optical port.

8147865, Apr 3, 2012

Jun 23, 2006

11/474149

Glenn T. Huang - Fremont CA, US
Thierry Nivaggioli - Atherton CA, US
Lon T. Spada - Walnut CA, US
Hiroshi Sugimoto - Huntington Beach CA, US
Wendy M. Blanda - Tustin CA, US
James N. Chang - Newport Beach CA, US
Orest Olejnik - Coto de Caza CA, US

Allergan, Inc. - Irvine CA

A61F 2/14

424427

Biocompatible intraocular implants include a steroid and an auxiliary agent, where the auxiliary agent is present in an amount sufficient to lessen the severity of at least one side effect compared to the use of an otherwise identical implant lacking said auxiliary agent. The steroid and the auxiliary agent may be present on the same intraocular implant or on different implants. The steroid and auxiliary agent may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. Or, the steroid may be associated with a polymeric coating having one or more openings effective to permit the steroid to be released into an external environment. The implants containing the steroid and an auxiliary agent may be placed in an eye to treat one or more ocular conditions while reducing the side effects otherwise accompanying steroid use.

8257730, Sep 4, 2012

Apr 29, 2005

11/118288

Glenn T. Huang - Fremont CA, US
Thierry Nivaggioli - Los Altos Hills CA, US
Lon T. Spada - Walnut CA, US
Hiroshi Sugimoto - Huntington Beach CA, US
Wendy M Blanda - Tustin CA, US
James N. Chang - Newport Beach CA, US
Orest Olejnik - Coto de Caza CA, US

Allergan, Inc. - Irvine CA

A61F 2/00

424427

Biocompatible intraocular implants include a steroid and a polymer associated with each other to facilitate release of the steroid into an eye for a period of time greater than about two months. The steroid may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. Or, the steroid may be associated with a polymeric coating having one or more openings effective to permit the steroid to be released into an external environment. The implants may be placed in an eye to treat one or more ocular conditions. The steroid is released from the implant for more than about two months, and may be release for more than several years.

20030196680, Oct 23, 2003

Apr 19, 2002

10/126919

Chung Lee - Fremont CA, US
Oanh Nguyen - Union City CA, US
Wei Shiang Lee - Milpitas CA, US
Michael Solomensky - Fremont CA, US
Atul Kumar - Fremont CA, US
James Chang - Cupertino CA, US
Binh Nguyen - Cupertino CA, US

DIELECTRIC SYSTEMS, INC - Freemont CA

C23C016/00
C25F001/00

134/001100, 118/719000, 118/726000, 438/905000

A Process Module (“PM”) is designed to facilitate Transport Polymerization (“TP”) of precursors that are useful for preparations of low Dielectric Constant (“∈”) films. The PM consists primarily of a Material Delivery System (“MDS”) with a high temperature Vapor Phase Controller (“VFC”), a TP Reactor, a Treatment Chamber, a Deposition Chamber and a Pumping System. The PM is designed to facilitate TP for new precursors and for film deposition and stabilization processes.

20030198578, Oct 23, 2003

Apr 18, 2002

10/125626

Chung Lee - Fremont CA, US
Oanh Nguyen - Union City CA, US
Atul Kumar - Fremont CA, US
Jeff Wu - Palo Alto CA, US
Michael Solomensky - Fremont CA, US
James Chang - Cupertino CA, US
Binh Nguyen - Cupertino CA, US

DIELECTRIC SYSTEMS, INC. - Fremont CA

F28D017/00

422/138000, 422/198000, 422/134000, 422/206000

A multi-stage transport polymerization (“TP”) reactor useful for making a thin film for the fabrication of integrated circuits. One TP reactor has two distinct heating zones that facilitate the cracking of specific precursor materials. The multi-stage reactor comprises a first low temperature heating zone that heats incoming precursor materials to a temperature that is lower than the “cracking” temperature of the precursor. The second heating zone is maintained at a temperature useful for breaking the chemical bonds of a desired leaving groups in the selected precursor. Specialized heating bodies, which transfer heat to the precursor material in the low and high temperature zones, are used as elements of the invention that can simultaneously decrease the total volume and increase the inside surface area of the TP reactor. Chemistries of precursors used in the multi-stage reactor are also provided.

20050047927, Mar 3, 2005

Apr 7, 2004

10/820447

Chung Lee - Fremont CA, US
Oanh Nguyen - Union City CA, US
Wei Lee - Milpitas CA, US
Michael Solomensky - Fremont CA, US
Atul Kumar - Fremont CA, US
James Chung Chang - Cupertino CA, US
Binh Nguyen - Cupertino CA, US

F04B001/00

417152000, 417053000

A Process Module (“PM”) is designed to facilitate Transport Polymerization (“TP”) of precursors that are useful for preparations of low Dielectric Constant (“∈”) films. The PM consists primarily of a Material Delivery System (“MDS”) with a high temperature Vapor Phase Controller (“VFC”), a TP Reactor, a Treatment Chamber, a Deposition Chamber and a Pumping System. The PM is designed to facilitate TP for new precursors and for film deposition and stabilization processes.

20080145407, Jun 19, 2008

Oct 31, 2007

11/932373

Glenn T. Huang - Fremont CA, US
Thierry Nivaggioli - Atherton CA, US
Lon T. Spada - Walnut CA, US
Hiroshi Sugimoto - Huntington Beach CA, US
Wendy M. Blanda - Tustin CA, US
James N. Chang - Newport Beach CA, US
Orest Olejnik - Coto De Caza CA, US

ALLERGAN, INC. - Irvine CA

A61F 2/16
A61K 31/56
A61P 27/02

424428, 514178

Biocompatible intraocular implants include a steroid and an auxiliary agent, where the auxiliary agent is present in an amount sufficient to lessen the severity of at least one side effect compared to the use of an otherwise identical implant lacking said auxiliary agent. The steroid and the auxiliary agent may be present on the same intraocular implant or on different implants. The steroid and auxiliary agent may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. Or, the steroid may be associated with a polymeric coating having one or more openings effective to permit the steroid to be released into an external environment. The implants containing the steroid and an auxiliary agent may be placed in an eye to treat one or more ocular conditions while reducing the side effects otherwise accompanying steroid use.